Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes Published 12 months ago on May 25, 2023 By Related Topics: Trending Artificial Intelligence3 days ago CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention Artificial Intelligence7 days ago SUNRATE partners with YeePay to empower Chinese companies to navigate global expansion Uncategorized4 days ago Improving the Developer Journey in Crafting Artificial Intelligence Applications Uncategorized7 days ago Intel unveils AI-Platform Innovation for Paris 2024 Artificial Intelligence5 days ago Appdome Unveils World’s First Agentless Mobile EDR & MTD Artificial Intelligence3 days ago Bitrue expands Bitcoin Runes Offerings with GPTV Listing and Staking Options